Effect of Tai Chi as Treatment for IBS-C
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04132804 |
Recruitment Status :
Completed
First Posted : October 21, 2019
Results First Posted : October 29, 2021
Last Update Posted : July 27, 2022
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Interventional |
---|---|
Study Design | Allocation: N/A; Intervention Model: Single Group Assignment; Masking: None (Open Label); Primary Purpose: Treatment |
Condition |
Irritable Bowel Syndrome With Constipation |
Intervention |
Behavioral: Tai Chi |
Enrollment | 31 |
Recruitment Details | |
Pre-assignment Details |
Arm/Group Title | Tai Chi Treatment |
---|---|
![]() |
All patients in the trial will receive 1-hour Tai Chi lessons once per week for a total of 8 weeks. Tai Chi: Tai Chi Chuan (taijiquan) or Tai Chi is a mind-body practice borne of Chinese philosophy and martial arts which has been practiced for centuries to promote deep relaxation, strengthened health, and to prevent injuries and illness. |
Period Title: Overall Study | |
Started | 31 |
Completed | 20 |
Not Completed | 11 |
Arm/Group Title | Tai Chi Treatment | |
---|---|---|
![]() |
All patients in the trial will receive 1-hour Tai Chi lessons once per week for a total of 8 weeks. Tai Chi: Tai Chi Chuan (taijiquan) or Tai Chi is a mind-body practice borne of Chinese philosophy and martial arts which has been practiced for centuries to promote deep relaxation, strengthened health, and to prevent injuries and illness. |
|
Overall Number of Baseline Participants | 31 | |
![]() |
[Not Specified]
|
|
Age, Categorical
Measure Type: Count of Participants Unit of measure: Participants |
||
Number Analyzed | 31 participants | |
<=18 years |
0 0.0%
|
|
Between 18 and 65 years |
27 87.1%
|
|
>=65 years |
4 12.9%
|
|
Age, Continuous
Mean (Standard Deviation) Unit of measure: Years |
||
Number Analyzed | 31 participants | |
42.2 (15.7) | ||
Sex: Female, Male
Measure Type: Count of Participants Unit of measure: Participants |
||
Number Analyzed | 31 participants | |
Female |
29 93.5%
|
|
Male |
2 6.5%
|
|
Ethnicity (NIH/OMB)
Measure Type: Count of Participants Unit of measure: Participants |
||
Number Analyzed | 31 participants | |
Hispanic or Latino |
2 6.5%
|
|
Not Hispanic or Latino |
29 93.5%
|
|
Unknown or Not Reported |
0 0.0%
|
|
Race (NIH/OMB)
Measure Type: Count of Participants Unit of measure: Participants |
||
Number Analyzed | 31 participants | |
American Indian or Alaska Native |
0 0.0%
|
|
Asian |
7 22.6%
|
|
Native Hawaiian or Other Pacific Islander |
3 9.7%
|
|
Black or African American |
1 3.2%
|
|
White |
20 64.5%
|
|
More than one race |
0 0.0%
|
|
Unknown or Not Reported |
0 0.0%
|
|
Region of Enrollment
Measure Type: Number Unit of measure: Participants |
||
United States | Number Analyzed | 31 participants |
31 | ||
Body Mass Index, kg/m^2
Mean (Standard Deviation) Unit of measure: Kg/m^2 |
||
Number Analyzed | 31 participants | |
23.4 (4.6) | ||
Waist circumference, cm
Mean (Standard Deviation) Unit of measure: Cm |
||
Number Analyzed | 31 participants | |
85.4 (10.9) | ||
IBS Symptom Severity Score
Mean (Standard Deviation) Unit of measure: Score on a scale |
||
Number Analyzed | 31 participants | |
232.8 (110.3) | ||
Hospital Anxiety and Depression Score
Mean (Standard Deviation) Unit of measure: Score on a scale |
||
Number Analyzed | 31 participants | |
15.1 (6.1) | ||
IBS Quality of Life Score
Mean (Standard Deviation) Unit of measure: Score on a scale |
||
Number Analyzed | 31 participants | |
91.0 (31.5) | ||
Visceral Sensitivity Index Score
Mean (Standard Deviation) Unit of measure: Score on a scale |
||
Number Analyzed | 31 participants | |
48.4 (17.8) | ||
Visual Analogue Abdominal Pain Scale Score
Mean (Standard Deviation) Unit of measure: Score on a scale |
||
Number Analyzed | 31 participants | |
1.8 (0.8) | ||
Bowel movement frequency
Mean (Standard Deviation) Unit of measure: Movements per day |
||
Number Analyzed | 31 participants | |
1.4 (1.1) | ||
Constipation severity
Mean (Standard Deviation) Unit of measure: Score on a scale |
||
Number Analyzed | 31 participants | |
3.4 (2.6) | ||
Abdominal discomfort severity
Mean (Standard Deviation) Unit of measure: Score on a scale |
||
Number Analyzed | 31 participants | |
4.3 (2.3) | ||
Bloating severity
Mean (Standard Deviation) Unit of measure: Score on a scale |
||
Number Analyzed | 31 participants | |
5.0 (2.3) | ||
Global Assessment of Relief
Mean (Standard Deviation) Unit of measure: Score on a scale |
||
Number Analyzed | 31 participants | |
3.4 (0.9) |
Name/Title: | Dr. Kyle Staller |
Organization: | Massachusetts General Hospital |
Phone: | 617-726-5565 |
EMail: | kstaller@mgh.harvard.edu |
Responsible Party: | Kyle Staller, MD, MPH, Massachusetts General Hospital |
ClinicalTrials.gov Identifier: | NCT04132804 |
Other Study ID Numbers: |
2019P000361 |
First Submitted: | August 21, 2019 |
First Posted: | October 21, 2019 |
Results First Submitted: | August 31, 2021 |
Results First Posted: | October 29, 2021 |
Last Update Posted: | July 27, 2022 |